Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Annals of Behavioral Medicine
Published in: Annals of Behavioral Medicine 2/2011

01-04-2011 | Original Article

The Multiphase Optimization Strategy for Engineering Effective Tobacco Use Interventions

Authors: Linda M. Collins, Ph.D., Timothy B. Baker, Ph.D., Robin J. Mermelstein, Ph.D., Megan E. Piper, Ph.D., Douglas E. Jorenby, Ph.D., Stevens S. Smith, Ph.D., Bruce A. Christiansen, Ph.D., Tanya R. Schlam, Ph.D., Jessica W. Cook, Ph.D., Michael C. Fiore, MD, MPH, MBA

Published in: Annals of Behavioral Medicine | Issue 2/2011

Login to get access

Abstract

The multiphase optimization strategy (MOST) is a new methodological approach for building, optimizing, and evaluating multicomponent interventions. Conceptually rooted in engineering, MOST emphasizes efficiency and careful management of resources to move intervention science forward steadily and incrementally. MOST can be used to guide the evaluation of research evidence, develop an optimal intervention (the best set of intervention components), and enhance the translation of research findings, particularly type II translation. This article uses an ongoing study to illustrate the application of MOST in the evaluation of diverse intervention components derived from the phase-based framework reviewed in the companion article by Baker et al. (Ann Behav Med, in press, 2011). The article also discusses considerations, challenges, and potential benefits associated with using MOST and similar principled approaches to improving intervention efficacy, effectiveness, and cost-effectiveness. The applicability of this methodology may extend beyond smoking cessation to the development of behavioral interventions for other chronic health challenges.
Literature
1.
Baker TB, Mermelstein R, Collins LM, et al. New methods for tobacco dependence treatment research. Ann Behav Med. 2011; in press.
2.
Fiore MC, Bailey WC, Cohen SJ. Treating tobacco use and dependence: Clinical practice guideline. Rockville: U.S. Department of Health and Human Services, U.S. Public Health Service; 2000.
3.
Fiore MC, Jaen CR, Baker TB, et al. Treating tobacco use and dependence: 2008 update. Rockville: U.S. Department of Health and Human Services, U.S. Public Health Service; 2008.
4.
Collins LM, Murphy SA, Nair VN, Strecher VJ. A strategy for optimizing and evaluating behavioral interventions. Ann Behav Med. 2005;30(1):65–73.PubMedCrossRef
5.
Collins LM, Murphy SA, Strecher V. The Multiphase Optimization Strategy (MOST) and the Sequential Multiple Assignment Randomized Trial (SMART): New methods for more potent eHealth interventions. Am J Prev Med. 2007;32(5 Suppl):S112–8.PubMedCrossRef
6.
Hollis JF, Bills R, Whitlock E, Stevens VJ, Mullooly J, Lichtenstein E. Implementing tobacco interventions in the real world of managed care. Tob Control. 2000;9(Suppl 1):I18–124.PubMedCrossRef
7.
Hung DY, Shelley DR. Multilevel analysis of the Chronic Care Model and 5A services for treating tobacco use in urban primary care clinics. Health Serv Res. 2008;44:103–27.PubMedCrossRef
8.
Kottke TE, Solberg LI, Brekke ML, Cabrera A, Marquez MA. Delivery rates for preventive services in 44 Midwestern clinics. Mayo Clin Proc. 1997;72(6):515–23.PubMedCrossRef
9.
Glasgow RE, Emmons KM. How can we increase translation of research into practice? Types of evidence needed. Annu Rev Public Health. 2007;28:413–33.PubMedCrossRef
10.
Glasgow RE, Lichtenstein E, Marcus AC. Why don't we see more translation of health promotion research to practice? Rethinking the efficacy-to-effectiveness transition. Am J Public Health. 2003;93(8):1261–7.PubMedCrossRef
11.
Box GEP, Hunter, W.G., & Hunter, J.S. Statistics for experimenters: An introduction to design, data analysis, and model building. New York: Wiley; 1978.
12.
Wu CF, Hamada M. Experiments: Planning, analysis, and parameter design optimization. New York: Wiley; 2000.
13.
Shadish WR, Cook TD, Campbell DT. Experimental and quasi-experimental designs for generalized causal inference. Boston: Houghton-Mifflin; 2002.
14.
Campbell MK, Mollison J, Steen N, Grimshaw JM, Eccles M. Analysis of cluster randomized trials in primary care: A practical approach. Fam Pract. 2000;17(2):192–6.PubMedCrossRef
15.
Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M. Developing and evaluating complex interventions: The new Medical Research Council guidance. BMJ. 2008;337:a1655.PubMedCrossRef
16.
Rose JE, Behm FM, Westman EC, Kukovich P. Precessation treatment with nicotine skin patch facilitates smoking cessation. Nicotine Tob Res. 2006;8(1):89–101.PubMedCrossRef
17.
Moore D, Aveyard P, Connock M, Wang D, Fry-Smith A, Barton P. Effectiveness and safety of nicotine replacement therapy assisted reduction to stop smoking: Systematic review and meta-analysis. BMJ. 2009;338:b1024.PubMedCrossRef
18.
Hughes JR, Carpenter MJ. The feasibility of smoking reduction: An update. Addiction. 2005;100(8):1074–89.PubMedCrossRef
19.
Hollis JF, McAfee TA, Fellows JL, Zbikowski SM, Stark M, Riedlinger K. The effectiveness and cost effectiveness of telephone counselling and the nicotine patch in a state tobacco quitline. Tob Control. 2007;16 Suppl 1:i53–9.PubMedCrossRef
20.
Zhu SH, Stretch V, Balabanis M, Rosbrook B, Sadler G, Pierce JP. Telephone counseling for smoking cessation: Effects of single-session and multiple-session interventions. J Consult Clin Psychol. 1996;64(1):202–11.PubMedCrossRef
21.
Zhu SH, Tedeschi G, Anderson CM, et al. Telephone counseling as adjuvant treatment for nicotine replacement therapy in a “real-world” setting. Prev Med. 2000;31(4):357–63.PubMedCrossRef
22.
Zhu SH, Anderson CM, Tedeschi GJ, et al. Evidence of real-world effectiveness of a telephone quitline for smokers. New Engl J Med. 2002;347(14):1087–93.PubMedCrossRef
23.
Tonstad S, Tonnesen P, Hajek P, Williams KE, Billing CB, Reeves KR. Effect of maintenance therapy with varenicline on smoking cessation: A randomized controlled trial. JAMA. 2006;296(1):64–71.PubMedCrossRef
24.
Covey LS, Glassman AH, Jiang H, et al. A randomized trial of bupropion and/or nicotine gum as maintenance treatment for preventing smoking relapse. Addiction. 2007;102(8):1292–302.PubMedCrossRef
25.
Hays JT, Hurt RD, Rigotti NA, et al. Sustained-release bupropion for pharmacologic relapse prevention after smoking cessation. A randomized, controlled trial. Ann Intern Med. 2001;135(6):423–33.PubMed
26.
Dale Horst W, Klein MW, Williams D, Werder SF. Extended use of nicotine replacement therapy to maintain smoking cessation in persons with schizophrenia. Neuropsychiatr Dis Treat. 2005;1(4):349–55.PubMed
27.
Helgason AR, Tomson T, Lund KE, Galanti R, Ahnve S, Gilljam H. Factors related to abstinence in a telephone helpline for smoking cessation. Eur J Public Health. 2004;14(3):306–10.PubMedCrossRef
28.
Fiore MC, Smith SS, Jorenby DE, Baker TB. The effectiveness of the nicotine patch for smoking cessation. A meta-analysis. JAMA. 1994;271(24):1940–7.PubMedCrossRef
29.
Piper ME, Federmen EB, McCarthy DE, et al. Using mediational models to explore the nature of tobacco motivation and tobacco treatment effects. J Abnorm Psychol. 2008;117(1):94–105.PubMedCrossRef
30.
Jorenby DE, Hays JT, Rigotti NA, et al. Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: A randomized controlled trial. JAMA. 2006;296(1):56–63.PubMedCrossRef
31.
Ferguson SG, Shiffman S, Gwaltney CJ. Does reducing withdrawal severity mediate nicotine patch efficacy? A randomized clinical trial. J Consult Clin Psychol. 2006;74(6):1153–61.PubMedCrossRef
32.
Shiffman S, Scharf DM, Shadel WG, et al. Analyzing milestones in smoking cessation: Illustration in a nicotine patch trial in adult smokers. J Consult Clin Psychol. 2006;74(2):276–85.PubMedCrossRef
33.
Collins LM, Dziak JJ, Li R. Design of experiments with multiple independent variables: A resource management perspective on complete and reduced factorial designs. Psychol Methods. 2009;14(3):202–24.PubMedCrossRef
34.
Fisher RA. The arrangement of field experiments. Journal of the Ministry of Agriculture of Great Britain. 1926;33:505–13.
35.
Chakraborty H. The design and analysis aspects of cluster randomized trials. In: Biswas A, Datta S, Fine JP, Segal MR, eds. Statistical Advances in the Biomedical Sciences. Hoboken: Wiley; 2008:67–80.
36.
SAS Institute. SAS/STAT 9.1 User's Guide. Cary: SAS Institute; 2004.
37.
SAS Institute. SAS/QC9.1 User's Guide. Cary: SAS Institute; 2004.
38.
Rivera DE, Pew MD, Collins LM. Using engineering control principles to inform the design of adaptive interventions: A conceptual introduction. Drug Alcohol Depend. 2007;88 Suppl 2:S31–40.PubMedCrossRef
39.
Zafra-Cabeza A, Rivera DE, Collins LM, Riado MA, Camacho EF. A risk-based model predictive control approach to adaptive interventions in behavioral health. Proceedings of the 45th IEEE Conference on Decision and Control. 2006:673–8.
40.
Carroll KM, Rounsaville BJ. Bridging the gap: A hybrid model to link efficacy and effectiveness research in substance abuse treatment. Psychiatr Serv. 2003;54(3):333–9.PubMedCrossRef
41.
Carroll KM, Rounsaville BJ. A vision of the next generation of behavioral therapies research in the addictions. Addiction. 2007;102(6):850–62; discussion 63–9.PubMedCrossRef
42.
Hopkins DP, Briss PA, Ricard CJ, et al. Reviews of evidence regarding interventions to reduce tobacco use and exposure to environmental tobacco smoke. Am J Prev Med. 2001;20(2 Suppl):16–66.PubMedCrossRef
43.
Hopkins DP, Husten CG, Fielding JE, Rosenquist JN, Westphal LL. Evidence reviews and recommendations on interventions to reduce tobacco use and exposure to environmental tobacco smoke: A summary of selected guidelines. Am J Prev Med. 2001;20(2 Suppl):67–87.PubMedCrossRef
44.
Glasgow RE, Klesges LM, Dzewaltowski DA, Bull SS, Estabrooks P. The future of health behavior change research: What is needed to improve translation of research into health promotion practice? Ann Behav Med. 2004;27(1):3–12.PubMedCrossRef
45.
Glasgow RE, Orleans CT, Wagner EH. Does the chronic care model serve also as a template for improving prevention? Milbank Q. 2001;79(4):579–612, iv–v.PubMedCrossRef
46.
McLellan A, Lewis, DC, O'Brein, CP, Kleber, HD. Drug dependence, a chronic medical illness: Implications for treatment, insurance, and outcomes evaluation. JAMA. 2000;284(13):1689–95.PubMedCrossRef
47.
Hung DY, Rundall TG, Tallia AF, Cohen DJ, Halpin HA, Crabtree BF. Rethinking prevention in primary care: Applying the chronic care model to address health risk behaviors. Milbank Q. 2007;85(1):69–91.PubMedCrossRef
48.
Kreps GL, Neuhauser L. New directions in eHealth communication: Opportunities and challenges. Patient Educ Couns. 2010;78(3):329–36.PubMedCrossRef
49.
Friend K, Levy DT. Smoking treatment interventions and policies to promote their use: A critical review. Nicotine Tob Res. 2001;3(4):299–310.PubMedCrossRef
50.
51.
Centers for Disease Control and Prevention. Use of FDA-approved pharmacological treatments for tobacco dependence—United States, 1984–1998. MMWR. 2000;49:665–8.
52.
Rothemich SF, Woolf SH, Johnson RE, et al. Effect on cessation counseling of documenting smoking status as a routine vital sign: An ACORN study. Ann Fam Med. 2008;6(1):60–8.PubMedCrossRef
53.
Fiore MC, Bailey WC, Cohen SJ. Smoking cessation: Clinical practice guideline no. 18. Rockville: U.S. Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research; 1996.
54.
Japuntich SJ, Zehner ME, Smith SS, et al. Smoking cessation via the internet: A randomized clinical trial of an internet intervention as adjuvant treatment in a smoking cessation intervention. Nicotine Tob Res. 2006;8 Suppl 1:S59–67.PubMedCrossRef
55.
Strecher VJ, McClure J, Alexander G, et al. Web-based smoking cessation components and tailoring depth: Results of a randomized trial. Am J Prev Med. 2008;34:373–81.PubMedCrossRef
56.
Kenford SL, Fiore MC, Jorenby DE, Smith SS, Wetter D, Baker TB. Predicting smoking cessation. Who will quit with and without the nicotine patch. JAMA. 1994;271(8):589–94.PubMedCrossRef
57.
Collins LM, Murphy SA, Bierman KL. A conceptual framework for adaptive preventive interventions. Prev Sci. 2004;5(3):185–96.PubMedCrossRef
58.
Murphy SA, Lynch KG, Oslin D, McKay JR, TenHave T. Developing adaptive treatment strategies in substance abuse research. Drug Alcohol Depend. 2007;88 Suppl 2:S24–30.PubMedCrossRef
Metadata
Title
The Multiphase Optimization Strategy for Engineering Effective Tobacco Use Interventions
Authors
Linda M. Collins, Ph.D.
Timothy B. Baker, Ph.D.
Robin J. Mermelstein, Ph.D.
Megan E. Piper, Ph.D.
Douglas E. Jorenby, Ph.D.
Stevens S. Smith, Ph.D.
Bruce A. Christiansen, Ph.D.
Tanya R. Schlam, Ph.D.
Jessica W. Cook, Ph.D.
Michael C. Fiore, MD, MPH, MBA
Publication date
01-04-2011
Publisher
Springer-Verlag
Published in
Annals of Behavioral Medicine / Issue 2/2011
Print ISSN: 0883-6612
Electronic ISSN: 1532-4796
DOI
https://doi.org/10.1007/s12160-010-9253-x

Other articles of this Issue 2/2011

Annals of Behavioral Medicine 2/2011 Go to the issue

Original Article

Heart Disease Occurs in a Biological, Psychological, and Social Matrix: Cardiac Risk Factors, Symptom Presentation, and Recovery as Illustrative Examples

Original Article

The Effect of Telephone-Administered Cognitive–Behavioral Therapy on Quality of Life among Patients with Multiple Sclerosis

Original Article

Cognitive Science Speaks to the “Common-Sense” of Chronic Illness Management

Introduction

Introduction to the Special Edition of Keynote Addresses and Master Lectures Presented at the 2010 Annual Meeting of the Society of Behavioral Medicine

Rapid Communication

Trait Anxiety Predicts Outcome 6 Weeks After Cholecystectomy. A Prospective Follow-Up Study

Original Article

New Methods for Tobacco Dependence Treatment Research